Neurocrine Biosciences, INC.
Science focused biopharma company focused on neuro, endo and psych disorders
Based in CA
AI Overview
With $1.7M in lobbying spend across 18 quarterly filings, Neurocrine Biosciences, INC is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 3 issue areas. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $290K |
| 2022 | $320K |
| 2023 | $320K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations
Telehealth, CMS coverage and reimbursement, user fee reauthorizations
S. Con. Res. 5 (117)
H.R. 1319, American Rescue Plan of 2021 implementation
prescription drug pricing
payment reform
innovation
S. Con. Res. 5 (117)
reconciliation
reconciliation
S. Con. Res. 14
Showing 8 of 19 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.